Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation.

Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502.

2.

PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.

Santos N, Rodríguez-Romanos R, de la Cámara R, Brunet S, Nieto JB, Buño I, Martínez C, Jiménez-Velasco A, Vallejo C, González M, Solano C, Ferrá C, Sampol A, Pérez-Simón JA, López-Jiménez J, Díez JL, Gallardo D; GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH).

Ann Hematol. 2018 Jul 17. doi: 10.1007/s00277-018-3438-y. [Epub ahead of print]

PMID:
30019128
3.

Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.

Martín I, Navarro B, Villamón E, Solano C, Serrano A, Calabuig M, Amat P, Domingo F, Abellán R, García F, Olivares MD, Chaves FJ, Tormo M, Hernández-Boluda JC.

Exp Mol Pathol. 2018 Aug;105(1):139-143. doi: 10.1016/j.yexmp.2018.07.002. Epub 2018 Jul 11.

PMID:
30017658
4.

Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.

Solano C, Giménez E, Albert E, Mateo EM, Gómez M, Goterris R, Pérez A, Amat P, Hernández-Boluda JC, Poch M, Piñana JL, Navarro D.

Bone Marrow Transplant. 2018 Jun 13. doi: 10.1038/s41409-018-0251-0. [Epub ahead of print]

PMID:
29899574
5.

Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain.

Martí E, Segado A, Pastor-Galán I, Amat P, Remigia MJ, Solano C, Navarro B.

Future Cardiol. 2018 May;14(3s):3-8. doi: 10.2217/fca-2018-0020.

PMID:
29848095
6.

Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.

Piñana JL, Gómez MD, Pérez A, Madrid S, Balaguer-Roselló A, Giménez E, Montoro J, González EM, Vinuesa V, Moles P, Hernández-Boluda JC, Salavert M, Calabuig M, Sanz G, Solano C, Sanz J, Navarro D.

Transpl Infect Dis. 2018 May 29:e12926. doi: 10.1111/tid.12926. [Epub ahead of print]

PMID:
29809298
7.

Practical Considerations in the Design and Use of Immunologically Active Fibrillar Peptide Assemblies.

Solano CM, Wen Y, Han H, Collier JH.

Methods Mol Biol. 2018;1777:233-248. doi: 10.1007/978-1-4939-7811-3_14.

PMID:
29744839
8.

Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation.

Albert E, Torres I, Talaya A, Giménez E, Piñana JL, Hernández-Boluda JC, Focosi D, Macera L, Maggi F, Solano C, Navarro D.

J Med Virol. 2018 Sep;90(9):1438-1443. doi: 10.1002/jmv.25218. Epub 2018 May 25.

PMID:
29727487
9.

Validation of a plasma metabolomics model that allows anticipation of the occurrence of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients.

Monleón D, Talaya A, Giménez E, Vinuesa V, Morales JM, Hernández-Boluda JC, Pérez A, Piñana JL, Solano C, Navarro D.

J Med Microbiol. 2018 May 4. doi: 10.1099/jmm.0.000746. [Epub ahead of print]

PMID:
29724268
10.

Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?

Solano C, Talaya A, Giménez E, Albert E, Piñana JL, Hernández-Boluda JC, Pérez A, Navarro D.

Bone Marrow Transplant. 2018 Jun;53(6):787-790. doi: 10.1038/s41409-018-0191-8. Epub 2018 Apr 26. No abstract available.

PMID:
29700479
11.

Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Pascual T, Solano C, Torres I, Talaya A, Giménez E, Vinuesa V, Piñana JL, Hernández-Boluda JC, Pérez A, Navarro D.

J Med Virol. 2018 Aug;90(8):1375-1382. doi: 10.1002/jmv.25185. Epub 2018 Apr 26.

PMID:
29663435
12.

Cytomegalovirus DNAemia Burden and Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation: An Area Under a Curve-Based Investigational Approach.

Giménez E, Solano C, Vinuesa V, Hernández-Boluda JC, Albert E, Pérez A, Piñana JL, Navarro D.

Clin Infect Dis. 2018 Mar 29. doi: 10.1093/cid/ciy138. [Epub ahead of print] No abstract available.

PMID:
29617736
13.

Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation.

Piñana JL, Perez-Pitarch A, Guglieri-Lopez B, Giménez E, Hernandez-Boluda JC, Terol MJ, Ferriols-Lisart R, Solano C, Navarro D.

Am J Transplant. 2018 Mar 30. doi: 10.1111/ajt.14754. [Epub ahead of print]

PMID:
29603596
14.

A Systematic Evaluation of the Two-Component Systems Network Reveals That ArlRS Is a Key Regulator of Catheter Colonization by Staphylococcus aureus.

Burgui S, Gil C, Solano C, Lasa I, Valle J.

Front Microbiol. 2018 Mar 7;9:342. doi: 10.3389/fmicb.2018.00342. eCollection 2018.

15.

Sensory deprivation in Staphylococcus aureus.

Villanueva M, García B, Valle J, Rapún B, Ruiz de Los Mozos I, Solano C, Martí M, Penadés JR, Toledo-Arana A, Lasa I.

Nat Commun. 2018 Feb 6;9(1):523. doi: 10.1038/s41467-018-02949-y.

16.

Polymicrobial infections: Do bacteria behave differently depending on their neighbours?

Lasa I, Solano C.

Virulence. 2018 Dec 31;9(1):895-897. doi: 10.1080/21505594.2018.1426520.

17.

The regulon of the RNA chaperone CspA and its auto-regulation in Staphylococcus aureus.

Caballero CJ, Menendez-Gil P, Catalan-Moreno A, Vergara-Irigaray M, García B, Segura V, Irurzun N, Villanueva M, Ruiz de Los Mozos I, Solano C, Lasa I, Toledo-Arana A.

Nucleic Acids Res. 2018 Feb 16;46(3):1345-1361. doi: 10.1093/nar/gkx1284.

18.

Enrofloxacin Permeation Pathways across the Porin OmpC.

Prajapati JD, Solano CJF, Winterhalter M, Kleinekathöfer U.

J Phys Chem B. 2018 Feb 1;122(4):1417-1426. doi: 10.1021/acs.jpcb.7b12568. Epub 2018 Jan 22.

PMID:
29307192
19.

CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .

Barba P, Martino R, Zhou Q, Cho C, Castro-Malaspina H, Devlin S, Esquirol A, Giralt S, Jakubowski AA, Caballero D, Maloy M, Papadopoulos EB, Piñana JL, Fox ML, Márquez-Malaver FJ, Valcárcel D, Solano C, López-Corral L, Sierra J, Perales MA.

Biol Blood Marrow Transplant. 2018 May;24(5):964-972. doi: 10.1016/j.bbmt.2017.12.804. Epub 2018 Jan 2.

PMID:
29305194
20.

Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia.

Sanz J, Kwon M, Bautista G, Sanz MA, Balsalobre P, Piñana JL, Solano C, Duarte R, Ferrá C, Lorenzo I, Martín C, Barba P, Pascual MJ, Martino R, Gayoso J, Buño I, Regidor C, de la Iglesia A, Montoro J, Díez-Martín JL, Sanz GF, Cabrera R.

Blood Adv. 2017 Jun 20;1(15):1047-1055. doi: 10.1182/bloodadvances.2017006999. eCollection 2017 Jun 27.

21.

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.

van Gorkom G, van Gelder M, Eikema DJ, Blok HJ, van Lint MT, Koc Y, Ciceri F, Beelen D, Chevallier P, Selleslag D, Blaise D, Foá R, Corradini P, Castagna L, Moreno C, Solano C, Müller LP, Tischer J, Hilgendorf I, Hallek M, Bittenbring J, Theobald M, Schetelig J, Kröger N; CLL subcommittee; Chronic Malignancies Working Party of the EBMT.

Bone Marrow Transplant. 2018 Mar;53(3):255-263. doi: 10.1038/s41409-017-0023-2. Epub 2017 Dec 18.

PMID:
29255169
22.

Bisexuality among a cohort of university students: prevalence and psychological distress.

Ciocca G, Solano C, Di Lorenzo G, Limoncin E, Mollaioli D, Carosa E, Collazzoni A, Santarnecchi E, Bianciardi E, Niolu C, Siracusano A, Rossi A, Jannini EA.

Int J Impot Res. 2018 Apr;30(2):79-84. doi: 10.1038/s41443-017-0014-2. Epub 2017 Dec 4.

PMID:
29203843
23.

Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study.

Piñana JL, Madrid S, Pérez A, Hernández-Boluda JC, Giménez E, Terol MJ, Calabuig M, Navarro D, Solano C.

Biol Blood Marrow Transplant. 2018 Mar;24(3):563-570. doi: 10.1016/j.bbmt.2017.11.001. Epub 2017 Nov 15.

PMID:
29155041
24.

Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.

Tormo M, Pérez-Martínez A, Calabuig M, Hernández-Boluda JC, Amat P, Navarro D, Solano C.

Mycoses. 2018 Mar;61(3):206-212. doi: 10.1111/myc.12728. Epub 2018 Jan 3.

PMID:
29125660
25.

Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?

Solano C, Mateo EM, Pérez A, Talaya A, Terol MJ, Albert E, Giménez E, Vinuesa V, Piñana JL, Boluda JCH, Navarro D.

J Clin Virol. 2017 Dec;97:26-32. doi: 10.1016/j.jcv.2017.10.016. Epub 2017 Nov 3.

PMID:
29096390
26.

The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Albert E, Solano C, Giménez E, Focosi D, Pérez A, Macera L, Piñana JL, Boluda JCH, Maggi F, Navarro D.

Bone Marrow Transplant. 2018 Feb;53(2):180-187. doi: 10.1038/bmt.2017.235. Epub 2017 Oct 30.

PMID:
29084205
27.

The impact of virus population diversity on the dynamics of cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.

Vinuesa V, Bracho MA, Albert E, Solano C, Torres-Puente M, Giménez E, González-Candelas F, Navarro D.

J Gen Virol. 2017 Oct;98(10):2530-2542. doi: 10.1099/jgv.0.000916. Epub 2017 Sep 6.

PMID:
28874227
28.

Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.

Albert E, Solano C, Pascual T, Torres I, Macera L, Focosi D, Maggi F, Giménez E, Amat P, Navarro D.

J Clin Virol. 2017 Sep;94:22-28. doi: 10.1016/j.jcv.2017.07.001. Epub 2017 Jul 8.

PMID:
28710997
29.

Assessing the risk of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients by monitoring oxidative-stress markers in plasma.

Talaya A, Solano C, Giménez E, García Giménez JL, Vinuesa V, Alberola J, Pallardó FV, Navarro D.

J Gen Virol. 2017 Jul;98(7):1855-1863. doi: 10.1099/jgv.0.000838. Epub 2017 Jul 10.

PMID:
28691896
30.

Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study.

Jurado M, De La Mata C, Ruiz-García A, López-Fernández E, Espinosa O, Remigia MJ, Moratalla L, Goterris R, García-Martín P, Ruiz-Cabello F, Garzón S, Pascual MJ, Espigado I, Solano C.

Cytotherapy. 2017 Aug;19(8):927-936. doi: 10.1016/j.jcyt.2017.05.002. Epub 2017 Jun 26.

PMID:
28662983
31.

When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?

Solano C, Giménez E, Piñana JL, Hernández-Boluda JC, Amat P, Vinuesa V, Navarro D.

Bone Marrow Transplant. 2017 Oct;52(10):1448-1451. doi: 10.1038/bmt.2017.109. Epub 2017 Jun 5. No abstract available.

PMID:
28581458
32.

A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.

Piñana JL, Hernández-Boluda JC, Calabuig M, Ballester I, Marín M, Madrid S, Teruel A, Terol MJ, Navarro D, Solano C.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12729. Epub 2017 Jul 17.

PMID:
28544152
33.

Lack of the PGA exopolysaccharide in Salmonella as an adaptive trait for survival in the host.

Echeverz M, García B, Sabalza A, Valle J, Gabaldón T, Solano C, Lasa I.

PLoS Genet. 2017 May 24;13(5):e1006816. doi: 10.1371/journal.pgen.1006816. eCollection 2017 May.

34.

Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.

Solano C, Giménez E, Piñana JL, Albert E, Vinuesa V, Hernández-Boluda JC, Amat P, Navarro D.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12717. Epub 2017 Jun 20.

PMID:
28471073
35.

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F.

Neurol Sci. 2017 Jul;38(7):1213-1221. doi: 10.1007/s10072-017-2933-6. Epub 2017 Apr 10.

36.

A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis.

Piñana JL, Perez-Pitarch A, Garcia-Cadenas I, Barba P, Hernandez-Boluda JC, Esquirol A, Fox ML, Terol MJ, Queraltó JM, Vima J, Valcarcel D, Ferriols-Lisart R, Sierra J, Solano C, Martino R.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1177-1185. doi: 10.1016/j.bbmt.2017.03.035. Epub 2017 Apr 7.

37.

Characterization of three new HLA Class I Alleles in Spanish Caucasians, HLA-A*02:620, HLA-B*27:150 and HLA-B*07:05:01:02.

Balas A, Planelles D, Montesinos P, Solano C, Vicario JL.

Int J Immunogenet. 2017 Jun;44(3):148-150. doi: 10.1111/iji.12317. Epub 2017 Apr 6.

PMID:
28383785
38.

Comparison of the artus Epstein-Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipients.

Vinuesa V, Solano C, Giménez E, Navarro D.

Diagn Microbiol Infect Dis. 2017 May;88(1):36-38. doi: 10.1016/j.diagmicrobio.2017.02.010. Epub 2017 Feb 24.

PMID:
28274502
39.

Comparing the influence of distinct kinds of temporal disorder in a low-dimensional absorbing transition model.

Solano CM, de Oliveira MM, Fiore CE.

Phys Rev E. 2016 Oct;94(4-1):042123. Epub 2016 Oct 19.

PMID:
27841620
40.

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.

Kharfan-Dabaja MA, Parody R, Perkins J, Lopez-Godino O, Lopez-Corral L, Vazquez L, Caballero D, Falantes J, Shapiro J, Ortí G, Barba P, Valcárcel D, Esquirol A, Martino R, Piñana JL, Solano C, Tsalatsanis A, Pidala J, Anasetti C, Perez-Simón JA.

Bone Marrow Transplant. 2017 Mar;52(3):438-444. doi: 10.1038/bmt.2016.269. Epub 2016 Nov 7.

PMID:
27819684
41.

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study.

Parody R, López-Corral L, Lopez-Godino O, Martinez C, Martino R, Solano C, Barba P, Caballero D, García-Cadenas I, Piñana JL, Marquez-Malaver FJ, Vazquez L, Esquirol A, Boluda JC, Sanchez-Guijo F, Pérez-Simon JA.

Bone Marrow Transplant. 2016 Nov;51(11):1524-1526. doi: 10.1038/bmt.2016.163. Epub 2016 Jun 13. No abstract available.

PMID:
27295268
42.

Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.

Vinuesa V, Solano C, Giménez E, Piñana JL, Boluda JC, Amat P, Navarro D.

Transpl Int. 2016 Nov;29(11):1196-1204. doi: 10.1111/tri.12831. Epub 2016 Sep 13.

43.

IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.

Corrales I, Solano C, Amat P, Giménez E, de la Cámara R, Nieto J, López J, García-Noblejas A, Piñana JL, Navarro D.

J Med Virol. 2017 Apr;89(4):685-695. doi: 10.1002/jmv.24676. Epub 2016 Sep 14.

PMID:
27591738
44.

Would Kinetic Analyses of Plasma Cytomegalovirus DNA Load Help to Reach Consensus Criteria for Triggering the Initiation of Preemptive Antiviral Therapy in Transplant Recipients?

Vinuesa V, Giménez E, Solano C, Gimeno C, Navarro D; Spanish Society for Infectious Diseases and Clinical Microbiology Quality Control Study Group.

Clin Infect Dis. 2016 Dec 1;63(11):1533-1535. Epub 2016 Aug 30. No abstract available.

PMID:
27578818
45.

How is the ultrasound in rheumatology used, implemented, and applied in Latin American centers? Results from a multicenter study.

Gutierrez M, Hernandez-Diaz C, Ventura-Rios L, Saldarriaga-Rivera LM, Ruta S, Alva M, -Trujillo CM, Pérez W, Terrazas H, Del Carmen Arape Toyo R, Quintero M, Solano C, Santiago OS, Sotomayor JG, Cefferino C, Py GE, Audisio MJ, Spindler WJ, Berman H, Airoldi C, Wong R, Del Castillo Araujo AL, Díaz ME, Villaquiran CC, Mantilla RD, Mendonça JA, da Silveira IG, do Prado AD, Bisi MC, Rosario V, Medrano-Sánchez J, Muñoz-Louis R, Lozada-Navarro AC, Bernal A, Lozano M, Pineda C; Pan-American League Against Rheumatisms (PANLAR) Ultrasound Study Group.

Clin Rheumatol. 2016 Dec;35(12):2893-2900. Epub 2016 Aug 30.

PMID:
27576331
46.

Continuous ambulatory peritoneal dialysis as a promising therapy for light chain amyloidosis with congestive heart failure.

Núñez J, Teruel A, Quiñones-Torrelo C, García-Blas S, Carratalá A, Miñana G, Santas E, Torregrosa I, Solano C, González M.

Int J Cardiol. 2016 Nov 15;223:807-809. doi: 10.1016/j.ijcard.2016.08.255. Epub 2016 Aug 20. No abstract available.

PMID:
27575781
47.

Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis.

Lupiañez CB, Villaescusa MT, Carvalho A, Springer J, Lackner M, Sánchez-Maldonado JM, Canet LM, Cunha C, Segura-Catena J, Alcazar-Fuoli L, Solano C, Fianchi L, Pagano L, Potenza L, Aguado JM, Luppi M, Cuenca-Estrella M, Lass-Flörl C, Einsele H, Vázquez L; PCRAGA Study Group, Ríos-Tamayo R, Loeffler J, Jurado M, Sainz J.

Front Microbiol. 2016 Aug 12;7:1243. doi: 10.3389/fmicb.2016.01243. eCollection 2016.

48.

Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.

Solano C, Slavin M, Shaul AJ, Marks DI, Cordonnier C, Cornely OA, Pagliuca A, Cragin L, Jarque I, Garcia-Vidal C, Sorensen S, Vanness DJ, Charbonneau C, Barrueta JA, Peral C, De Salas-Cansado M, Bow EJ.

Mycoses. 2017 Feb;60(2):79-88. doi: 10.1111/myc.12552. Epub 2016 Aug 26.

PMID:
27562016
49.

Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine.

Latasa C, Echeverz M, García B, Gil C, García-Ona E, Burgui S, Casares N, Hervás-Stubbs S, Lasarte JJ, Lasa I, Solano C.

PLoS One. 2016 Aug 18;11(8):e0161216. doi: 10.1371/journal.pone.0161216. eCollection 2016.

50.

Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.

Kekre N, Marquez-Malaver FJ, Cabrero M, Piñana J, Esquirol A, Soiffer RJ, Caballero D, Terol MJ, Martino R, Antin JH, Lopez-Corral L, Solano C, Armand P, Pérez-Simon JA.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1808-1815. doi: 10.1016/j.bbmt.2016.07.006. Epub 2016 Jul 25.

Supplemental Content

Loading ...
Support Center